Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression. 1987

K Rickels, and H R Chung, and I B Csanalosi, and A M Hurowitz, and J London, and K Wiseman, and M Kaplan, and J D Amsterdam
Department of Psychiatry, University of Pennsylvania, Philadelphia.

Two hundred forty-one outpatients with a DSM-III diagnosis of major depressive disorder participated in a six-week double-blind therapeutic trial of alprazolam, diazepam, imipramine hydrochloride, and placebo. Side effects were given as a major reason for attrition by patients taking the three active compounds and ineffectiveness was the reason given by patients taking placebo. Imipramine-treated patients reported the most and placebo patients the least number of adverse effects. Imipramine and alprazolam, but not diazepam, produced significantly more improvement in depressed symptomatology than did placebo. Mean diazepam scores frequently assumed an intermediate position between those of imipramine or alprazolam and placebo. These treatment differences were found to be independent of initial severity levels of anxiety and depression.

UI MeSH Term Description Entries
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D008297 Male Males
D010555 Personality Inventory Check list, usually to be filled out by a person about himself, consisting of many statements about personal characteristics which the subject checks. Edwards Personal Preference Schedule,Myers-Briggs Type Indicator,Indicator, Myers-Briggs Type,Inventories, Personality,Inventory, Personality,Myers Briggs Type Indicator,Personality Inventories
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

K Rickels, and H R Chung, and I B Csanalosi, and A M Hurowitz, and J London, and K Wiseman, and M Kaplan, and J D Amsterdam
April 1989, International clinical psychopharmacology,
K Rickels, and H R Chung, and I B Csanalosi, and A M Hurowitz, and J London, and K Wiseman, and M Kaplan, and J D Amsterdam
May 1990, The Journal of clinical psychiatry,
K Rickels, and H R Chung, and I B Csanalosi, and A M Hurowitz, and J London, and K Wiseman, and M Kaplan, and J D Amsterdam
June 1983, JAMA,
K Rickels, and H R Chung, and I B Csanalosi, and A M Hurowitz, and J London, and K Wiseman, and M Kaplan, and J D Amsterdam
May 1993, Journal of affective disorders,
K Rickels, and H R Chung, and I B Csanalosi, and A M Hurowitz, and J London, and K Wiseman, and M Kaplan, and J D Amsterdam
March 1981, Journal of clinical psychopharmacology,
K Rickels, and H R Chung, and I B Csanalosi, and A M Hurowitz, and J London, and K Wiseman, and M Kaplan, and J D Amsterdam
July 1991, Pharmacopsychiatry,
K Rickels, and H R Chung, and I B Csanalosi, and A M Hurowitz, and J London, and K Wiseman, and M Kaplan, and J D Amsterdam
January 1990, Acta psychiatrica Scandinavica. Supplementum,
K Rickels, and H R Chung, and I B Csanalosi, and A M Hurowitz, and J London, and K Wiseman, and M Kaplan, and J D Amsterdam
June 1994, The British journal of psychiatry : the journal of mental science,
K Rickels, and H R Chung, and I B Csanalosi, and A M Hurowitz, and J London, and K Wiseman, and M Kaplan, and J D Amsterdam
February 1992, The Journal of clinical psychiatry,
K Rickels, and H R Chung, and I B Csanalosi, and A M Hurowitz, and J London, and K Wiseman, and M Kaplan, and J D Amsterdam
January 1982, International pharmacopsychiatry,
Copied contents to your clipboard!